Introduction: Who Should Undergo Diagnostics

Parents should seek medical evaluation when they notice their child developing signs of puberty unusually early. For girls, this means observing breast growth, the appearance of pubic or underarm hair, or menstrual periods before the typical age range. For boys, early signs include enlargement of the testicles or penis, facial hair, voice deepening, or rapid height increase. These physical changes, when they occur before age 8 in girls (or age 7 in some ethnic groups) and before age 9 in boys, warrant a visit to a healthcare professional.^[1]

It is particularly important to schedule an appointment if your child is experiencing not just one isolated change, but multiple signs of sexual maturation. Additionally, if your child is growing much faster than their classmates or if they seem emotionally distressed about looking different from their peers, these are good reasons to consult a doctor. Some children may also develop acne or adult body odor alongside other pubertal changes, which together suggest the body’s hormone system has become active too soon.^[4]

Early consultation matters because untreated precocious puberty can lead to shorter adult height than expected. This happens because the bones mature and stop growing earlier than they should. Children who start puberty too soon may initially be taller than their friends, but they often end up shorter as adults because their growth plates close prematurely. Beyond physical concerns, children going through puberty early may face emotional and social challenges, feeling self-conscious or confused about changes their peers are not yet experiencing.^[5]

Diagnostic Methods

Diagnosing precocious puberty begins with a thorough review of the child’s medical history and family background. The healthcare professional will ask questions about when the physical changes started, how quickly they have progressed, and whether other family members experienced early or late puberty. A detailed family history helps because the timing of puberty can run in families. Understanding the child’s overall health, any medications they take, and whether they have been exposed to hormone-containing products like creams or supplements also provides important clues.^[9]

The next step involves a careful physical examination. The doctor will measure the child’s height and weight and compare these measurements to standard growth charts. They will assess the stage of sexual development using a system called Tanner staging, which describes the progression of puberty based on physical characteristics such as breast development in girls or testicular size in boys. In girls, the doctor looks for breast tissue growth and pubic hair. In boys, they measure testicular volume and check for penile enlargement. These observations help determine whether the child is truly experiencing central puberty or just isolated changes.^[7]

Blood tests play a crucial role in confirming the diagnosis and understanding what type of precocious puberty is occurring. Doctors order tests to measure hormone levels including luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (a form of estrogen), and testosterone. Elevated levels of these hormones at an inappropriate age indicate that the reproductive system has become active too soon. Blood tests may also check thyroid function, because severe hypothyroidism—when the thyroid gland produces too little hormone—can sometimes trigger early puberty.^[7]

A specialized test called the gonadotropin-releasing hormone (GnRH) stimulation test helps identify which of the two main types of precocious puberty a child has. During this test, a blood sample is taken first, then the child receives an injection of GnRH hormone. Additional blood samples are collected over the following hours to see how the body responds. In children with central precocious puberty—where the brain is triggering early puberty—the GnRH injection causes LH and FSH levels to rise significantly. In children with peripheral precocious puberty—where the problem originates in the ovaries, testes, or adrenal glands rather than the brain—hormone levels remain unchanged after the GnRH injection.^[9]

X-rays of the child’s hand and wrist provide another valuable piece of information. These images reveal the child’s bone age, which indicates how mature the skeleton is. In precocious puberty, bone age is often significantly more advanced than the child’s actual age. For example, a seven-year-old girl might have the bone development of a ten-year-old. This accelerated bone maturation is concerning because it predicts early closure of the growth plates—the areas of developing tissue near the ends of long bones that determine final height.^[9]

When central precocious puberty is diagnosed, brain imaging with magnetic resonance imaging (MRI) may be recommended, especially in boys and in younger girls. This test creates detailed pictures of the brain to check for abnormalities such as tumors, cysts, or structural problems in the hypothalamus or pituitary gland—the brain regions that control puberty. While most girls with central precocious puberty have no identifiable brain abnormality, boys and very young children are more likely to have an underlying cause that the MRI can detect.^[9]

For children diagnosed with peripheral precocious puberty, additional testing focuses on finding the source of excess hormones. This might include ultrasound imaging of the ovaries in girls to look for cysts or tumors, or ultrasound of the testes in boys. Blood tests may check for elevated levels of human chorionic gonadotropin (HCG), a hormone that certain tumors produce. Imaging of the adrenal glands, which sit atop the kidneys and produce sex hormones, may also be necessary if doctors suspect an adrenal disorder.^[9]

Diagnostics for Clinical Trial Qualification

When children with precocious puberty are considered for participation in clinical trials, specific diagnostic criteria are used to ensure that enrolled participants truly have the condition and can benefit from the investigational treatment. Standard enrollment requirements typically include documentation of the child’s age and the timing when pubertal changes first appeared. Girls usually must show signs of puberty before age 8 (sometimes before age 7 or 7.5 years depending on the study), while boys must show signs before age 9.^[2]

Clinical trials commonly require laboratory confirmation through the GnRH stimulation test to verify central precocious puberty. This test must demonstrate that the child’s body responds to GnRH with elevated LH and FSH levels, proving that the brain-pituitary-gonadal system is activated. Specific threshold values for LH response after GnRH stimulation are often part of trial inclusion criteria, ensuring that only children with true central activation are enrolled.^[15]

Bone age assessment through hand and wrist X-rays is another standard requirement. Clinical trials typically specify that bone age must be advanced by at least one year beyond the child’s chronological age to qualify. This criterion helps identify children who are at risk for compromised adult height and who might benefit most from treatment. Some studies may also require that predicted adult height, calculated from current height and bone age measurements, falls below a certain threshold.^[15]

Imaging studies, particularly brain MRI, are often required before trial enrollment to rule out serious underlying conditions such as tumors or other structural abnormalities. Children with certain brain pathologies may be excluded from some studies, or they may be placed in separate study groups depending on the trial design. Documentation of physical examination findings using Tanner staging provides objective evidence of pubertal development and helps monitor response to treatment during the trial.^[11]

Additional baseline measurements collected for clinical trials might include repeated growth velocity assessments to document how quickly the child is growing, psychological assessments to evaluate emotional and behavioral impact, and quality of life questionnaires. Serial hormone measurements over time help researchers track how well an experimental treatment suppresses the hormonal activity driving early puberty. All of these diagnostic procedures serve both to qualify children for trials and to provide baseline data against which treatment effects can be measured.^[11]